VMED - Retatrutide Compound peptide Vial 30mg
Weight Management • Appetite Control • Metabolic Support
Advanced Triple Agonist Peptide for Metabolic Regulation & Weight Management
Product Overview V-Med Retatrutide 30mg is a cutting-edge investigational peptide representing the next generation of metabolic therapy. As a "tri-agonist," Retatrutide activates three key hormone receptors simultaneously: the glucagon-like peptide-1 (GLP-1) receptor, the glucose-dependent insulinotropic polypeptide (GIP) receptor, and the glucagon receptor. This multi-faceted mechanism offers superior potential for weight management, glucose homeostasis, and metabolic regulation compared to single or dual-agonist therapies.
Properties & Effects Clinical trials have demonstrated that Retatrutide facilitates profound metabolic changes, particularly in long-term use. Key benefits include:
- Significant Weight Loss: Delivers strong reductions in body weight and adipose tissue over time, especially at higher therapeutic dosages.
- Enhanced Metabolic Rate: Increases energy expenditure and thermogenesis by modulating glucagon action.
- Improved Glycemic Control: Enhances insulin sensitivity, regulates blood sugar, and supports insulin secretion when glucose levels are high.
- Appetite Suppression: Promotes increased satiety, reduces hunger signals, and lowers overall caloric intake by slowing gastric emptying.
- Cardiovascular Health: May improve lipid profiles, reduce inflammation markers, and lower cardiovascular risk factors associated with obesity.
Disclaimer
This product is intended strictly for laboratory research purposes only. It is not a medicine and has not been evaluated or approved by the South African Health Products Regulatory Authority (SAHPRA) for human or animal use.
Not for human consumption or medical use. Products sold on this website are not intended to diagnose, treat, cure, or prevent any disease. By purchasing, the customer confirms they are qualified to handle and use this product in accordance with applicable laws and regulations.
